Anthony De Angelis, | |
3900 Park Nicollet Blvd, St Louis Park, MN 55416-2503 | |
(952) 993-3123 | |
Not Available |
Full Name | Anthony De Angelis |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 41 Years |
Location | 3900 Park Nicollet Blvd, St Louis Park, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780668897 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 41374 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Park Nicollet Clinic | 7911819438 | 1529 |
News Archive
The National Oceanic and Atmospheric Administration and the U.S. Food and Drug Administration are taking additional steps to enhance inspection measures designed to ensure that seafood from the Gulf of Mexico reaching America's tables is safe to eat.
Bose Corporation has introduced DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices. Featuring proprietary Bose® controls and linear motor technology, the DuraPulse system enables research and development engineers to run tests at frequencies higher than ever before - exceeding 30 Hz without the loss of waveform fidelity. And with Bose PeakIQ™ control technology, the DuraPulse system also prevents high-pressure spikes during valve closing.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour.
› Verified 8 days ago
Entity Name | Park Nicollet Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
The National Oceanic and Atmospheric Administration and the U.S. Food and Drug Administration are taking additional steps to enhance inspection measures designed to ensure that seafood from the Gulf of Mexico reaching America's tables is safe to eat.
Bose Corporation has introduced DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices. Featuring proprietary Bose® controls and linear motor technology, the DuraPulse system enables research and development engineers to run tests at frequencies higher than ever before - exceeding 30 Hz without the loss of waveform fidelity. And with Bose PeakIQ™ control technology, the DuraPulse system also prevents high-pressure spikes during valve closing.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Anthony De Angelis, 6465 Wayzata Blvd, Suite 315, St Louis Park, MN 55426-1728 Ph: () - | Anthony De Angelis, 3900 Park Nicollet Blvd, St Louis Park, MN 55416-2503 Ph: (952) 993-3123 |
News Archive
The National Oceanic and Atmospheric Administration and the U.S. Food and Drug Administration are taking additional steps to enhance inspection measures designed to ensure that seafood from the Gulf of Mexico reaching America's tables is safe to eat.
Bose Corporation has introduced DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices. Featuring proprietary Bose® controls and linear motor technology, the DuraPulse system enables research and development engineers to run tests at frequencies higher than ever before - exceeding 30 Hz without the loss of waveform fidelity. And with Bose PeakIQ™ control technology, the DuraPulse system also prevents high-pressure spikes during valve closing.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour.
› Verified 8 days ago
Jane Nemecek, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3900 Park Nicollet Blvd, St Louis Park, MN 55416 Phone: 952-993-3017 | |
Dr. Marie Christensen, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3900 Park Nicollet Blvd, St Louis Park, MN 55416 Phone: 952-993-3504 |